Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

PATHOLOGY CONSULTANTS, INC

UEI: NPAST1X5TW47CAGE: 6T3F0

PATHOLOGY CONSULTANTS, INC is a federal contractor, registered under UEI NPAST1X5TW47 and CAGE code 6T3F0. It has been awarded $669,454 across 10 federal contracts. Primary work spans Medical Laboratories and Diagnostic Imaging Centers. Top awarding agencies include Department Of Defense and W40M Mrco Pacific.

Contact Information

Registration and classification details

Emailcontact@company.com

Phone+1 (555) 000-0000

Address123 Main St, City, ST 12345

Registration

UEI Code

NPAST1X5TW47

CAGE Code

6T3F0

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

2XA5XS

NAICS Codes

621511Medical Laboratories(Primary)

621512Diagnostic Imaging Centers

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Pathology Consultants, Inc. specializes in providing comprehensive non-personal pathology testing services to military medical facilities, with a focused expertise in clinical laboratory operations supporting Department of Defense healthcare networks. The contractor delivers high-compliance diagnost...

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Defense$416.0K62.1%

W40M Mrco Pacific$253.5K37.9%

Awards by NAICS

621511 - Medical Laboratories$636.6K95.1%

621512 - Diagnostic Imaging Centers$32.8K4.9%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in PATHOLOGY CONSULTANTS, INC's top NAICS codes and agencies

Trace Chemotherapy Waste HandlingThis contract involves the specialized handling and disposal of trace chemotherapy waste generated in oncology settings, including items such as IV bags, gloves, and gowns contaminated with cytotoxic agents. The work requires strict adherence to hazardous material protocols, with all waste destined for incineration at facilities authorized to process such materials, ensuring compliance with environmental and safety regulations. The subcontract is issued by San Diego County under NAICS code 621511 and is set to close for responses on August 8, 2026, with a posting date of July 24, 2026. Performance is expected to take place within San Diego, and the contract is not designated for any specific small business set-aside. All activities must be conducted under the highest standards of containment and regulatory oversight to protect public health and environmental integrity.

San Diego County

POSTED

DEADLINE

Drug Testing Laboratory Analysis ServicesTarrant County is seeking a subcontractor to provide forensic toxicology testing services on biological specimens including urine, blood, and hair, with strict adherence to chain-of-custody protocols, CJIS security standards, and all applicable regulatory reporting requirements. The contract falls under NAICS code 621511 and is positioned as a subcontract opportunity, with responses due by August 27, 2026. The work must ensure accurate, legally defensible results compliant with criminal justice and laboratory accreditation frameworks, though specific performance locations and point of contact details are not provided. Interested parties must engage through the designated online portal to submit proposals by the deadline.

POSTED

DEADLINE

in about 1 month

VA NWIHCS Pathology ServiceThe Nebraska-Western Iowa Health Care System is seeking market information to plan for a five-year, fixed-price, indefinite-delivery/indefinite-quantity contract to procure comprehensive Medical Laboratory and Pathology Services, including autopsy services, for three VA facilities in Omaha, Lincoln, and Grand Island, Nebraska. The contractor will be responsible for pre-analytic processing, analysis, reporting, and interpretation of clinical and anatomical pathology specimens, while the VA retains responsibility for specimen collection, grossing (except cytology), accessioning, preservation, and storage of all slides and blocks, which must be returned to VA for permanent retention. The contract will cover all testing services listed in Attachment B, with the NAICS code 621511 and PSC Q515, and will be executed over five annual ordering periods from April 2027 through March 2032. Responses to this sources-sought announcement are required by August 3, 2026, and must be submitted via email with specific documentation, including company details, SAM registration number, small business status, completed Attachment B with CLIA certifications for every testing location, and Attachment C. Contractors must provide verified reference contracts demonstrating proven experience in collecting, transporting, testing, and reporting results from remote healthcare facilities, with full details for each contract, including verification contacts. Any subcontractors involved must submit letters of commitment and their own CLIA certifications. Failure to provide complete CLIA documentation or verified experience information may result in the government determining the contractor lacks capability, impacting potential set-aside determinations. All responders must be registered in SAM and must understand this RFI is strictly for market research and does not constitute a solicitation or binding obligation.

Network Contract Office 23 (36C263)

POSTED

DEADLINE

Background Screening and Drug Testing ServicesThe contract requires the provision of pre-employment and random drug testing along with criminal background checks for security personnel, ensuring strict adherence to SAMHSA guidelines and applicable state regulations. Services must be delivered in a timely, accurate, and compliant manner to support the integrity and safety standards of security personnel under the jurisdiction of the Louisiana Department of Children & Family Services. The solicitation is classified as a subcontract with a NAICS code of 621511 and is open for responses until August 21, 2026, with no set-aside provisions designated. Performance is expected to align with Louisiana’s specific operational and regulatory requirements, though the exact location of service delivery is not specified in the posted details.

Department of Children & Family Services

POSTED

DEADLINE

PARENTAL DNA TESTING SERVICESThe County of Riverside, through its Purchasing & Fleet Department on behalf of the Department of Public Social Services, is soliciting qualified medical laboratory facilities accredited by the American Association of Blood Banks to provide genetic DNA parentage testing services. These services include standard DNA paternity testing and motherless case DNA testing to determine biological parentage, which is critical for establishing legal paternity in cases involving public assistance under Title IV-A of the Social Service Act or when directed by the Juvenile Court for adoption proceedings. The testing supports child welfare efforts by clarifying parental rights and responsibilities for individuals engaged in informally or formally recognized child welfare services or juvenile dependency cases. The solicitation, identified as DPARC-0683, was posted on July 23, 2026, with a response deadline of August 26, 2026. All services must be performed in California and are intended for clients referred by DPSS. Only laboratories accredited by the AABB are eligible to respond, ensuring adherence to high forensic and scientific standards. The primary point of contact for inquiries is Monica Mathis, reachable via email or phone, and additional details about the solicitation are available through the public procurement portal. The contract does not specify a set-aside designation and is open to all qualified AABB-accredited providers meeting the technical and operational requirements for DNA testing in a public social services context.

County of Riverside

POSTED

DEADLINE

in about 1 month

Follow Up FundsFunds have been allocated to support cancer screening services for uninsured individuals in the District of Columbia, with the objective of increasing access to early detection and preventive care. The initiative is managed by the Department of Health and is intended to reach populations that otherwise lack the means to obtain critical screenings, thereby addressing disparities in health outcomes. The opportunity was posted as a forecast on July 23, 2026, indicating future intent to award funding, though specific solicitation details, set-aside classifications, or NAICS codes have not yet been defined. The program will operate within the District of Columbia, with no designated place of performance or contact information provided at this stage. Interested parties should monitor the official contract portal for updates as the solicitation process develops.

POSTED

DEADLINE

URINALYSIS TESTING SERVICESThe contractor will be responsible for delivering urinalysis testing services to support the Pathways Program administered by the Neighborhood Safety and Engagement (ONSE) within the District of Columbia. The services are anticipated to begin following the forecast posting date of July 23, 2026, though specific start and end dates are not detailed. The contract does not designate a set-aside classification, nor does it specify a NAICS code, organization type, or detailed place of performance, indicating the scope is focused on the delivery of testing services without geographic or demographic restrictions outlined. No point of contact information is provided, and all performance locations remain unspecified, suggesting that the exact logistics and reporting protocols will be defined in subsequent procurement steps. The forecasting nature of this posting implies an intent to gather market interest ahead of formal solicitation.

Neighborhood Safety and Engagement (ONSE)

POSTED

DEADLINE

Postmortem Evaluation (Mayo Clinic))The contract pertains to postmortem genetic testing services to be conducted by the Mayo Clinic at the request of the District of Columbia’s Chief Medical Examiner’s Office. The purpose involves conducting forensic genetic analyses following death to assist in determining cause, manner, or identity in cases where traditional methods are insufficient or inconclusive. This forecasted procurement anticipates the need for advanced genomic screening, potentially including inherited condition detection, ancestry mapping, or familial DNA matching relevant to legal or investigative outcomes. While no solicitation number or set-aside details are provided, the posting date indicates the opportunity is in early stages of planning, with no specified performance location or point of contact listed. The procurement is managed under the District of Columbia’s Office of the Chief Medical Examiner and is intended to enhance the office’s capacity for scientifically rigorous postmortem evaluations.

Chief Medical Examiner (OCME)

POSTED

DEADLINE

Medical SurveillanceThe contract focuses on medical surveillance services specifically for tuberculosis and fitness testing, under the jurisdiction of the Chief Medical Examiner’s Office in the District of Columbia. It is listed as a forecast with a posting date of July 23, 2026, indicating it is a planned procurement not yet open for bids. The intent is to establish ongoing medical monitoring protocols to ensure the health and readiness of personnel, particularly in roles requiring physical fitness and exposure risk assessments. No solicitation number, NAICS code, or set-aside details are provided, and the place of performance and point of contact information remain unspecified, suggesting further details will be released in subsequent announcements. The contract is intended to support public health and safety standards within District of Columbia government operations.

Chief Medical Examiner (OCME)

POSTED

DEADLINE

TBDThe District of Columbia Department of Health has forecasted a future procurement for clinical laboratory testing services, with the solicitation expected to be released at a later date. The opportunity is designated as a forecast, indicating it is a preliminary notice rather than an active solicitation, and no specific set-aside type, NAICS code, or organizational restrictions have been identified at this time. The services are intended to support public health operations within the District, with performance likely centered in the District of Columbia, though the exact location and office details have not been provided. There is no point of contact listed, and interested parties should monitor the official contracting portal for updates on the upcoming solicitation.

POSTED

DEADLINE

TBD -TB Control Radiological Services (STD&TB)The contract titled TBD - TB Control Radiological Services (STD&TB) is a forecasted procurement issued by the District of Columbia Department of Health, indicating a future solicitation for radiological services related to tuberculosis control. Although the solicitation number and other details such as NAICS code, set-aside type, and organization type are not yet specified, the posting date of July 23, 2026, suggests this is a planned acquisition for the future, allowing potential vendors to prepare in advance. The place of performance and office address information remain undefined, implying that specific locations or service areas have not been finalized. There is no designated point of contact listed, which may indicate that communication channels or procurement representatives will be identified closer to the formal solicitation release. The forecast is accessible via a public portal, enabling interested parties to monitor updates and prepare responses ahead of the official bid cycle.

POSTED

DEADLINE

Health Screening Testing (Unit-Based)The contract pertains to the administration of discrete health screening tests, likely aimed at monitoring public or wildlife health under the jurisdiction of the Florida Fish and Wildlife Conservation Commission. It is structured as a subcontract with a NAICS code of 621511, indicating it relates to veterinary services, and is posted for response until August 13, 2026. The work will be performed within Florida, though specific location details are not provided, and the testing is expected to support surveillance or monitoring efforts critical to ecological or public health outcomes. There is no set-aside classification indicated, and the solicitation is open to eligible subcontractors who can deliver precise, unit-based screening services. All submissions must be made through the Florida Marketplace vendor portal prior to the deadline.

Florida Fish and Wildlife Conservation Commission

POSTED

DEADLINE

PCR-Based Fungal Pathogen DetectionThe contract requires the performance of multiplex PCR assays to detect specific fungal pathogens—Pneumocystis, Histoplasma, Blastomyces, and Coccidioides—in respiratory specimens, targeting accurate and efficient diagnosis of pulmonary fungal infections. The work must be delivered using a validated pulmonary fungal pathogen panel capable of simultaneously identifying these organisms from clinical samples, ensuring reliable results for patient care decisions. The contract is structured as a subcontract under the Department of Veterans Affairs, managed by the 250-NETWORK Contract Office 10, with a strict submission deadline of July 28, 2026, and a posting date of July 23, 2026, indicating an abbreviated response window. The nature of the work falls under NAICS code 621511, which designates medical and diagnostic laboratories, underscoring the need for compliance with clinical laboratory standards and quality assurance protocols. Performance is expected to meet stringent accuracy and timeliness requirements, though the exact location for service delivery is unspecified.

250-NETWORK Contract Office 10 (36C250)

POSTED

DEADLINE

Beta-D Glucan Testing via Colorimetric AssayThe contract calls for the performance of Beta-D Glucan testing using a colorimetric assay to support the detection and diagnosis of invasive fungal infections, with a primary focus on Pneumocystis and other fungi that produce Beta-D Glucan. This testing service is intended to provide critical diagnostic support in clinical settings where rapid and accurate identification of fungal pathogens is essential for timely patient management. The work is to be delivered under a subcontract arrangement, with the activity tied to the Department of Veterans Affairs through the 250-NETWORK Contract Office 10, and aligned with NAICS code 621511 for medical laboratories. The solicitation was posted on July 23, 2026, with a firm deadline for responses set for July 28, 2026, at 9:00 PM, indicating a narrow window for participation. Place of performance and specific office location details are not provided, suggesting flexibility in physical execution while maintaining strict adherence to the required testing methodology and diagnostic standards.

250-NETWORK Contract Office 10 (36C250)

POSTED

DEADLINE

Quantitative Fungal Antigen/Antibody Testing (EIA)The contract requires the performance of enzyme immunosorbent assay testing to quantitatively detect antigens and antibodies for four specific fungal pathogens: Histoplasma, Blastomyces, Coccidioides, and Aspergillus in clinical specimens. This work is part of a subcontract under the Department of Veterans Affairs’ 250-NETWORK Contract Office 10 and is classified under NAICS code 621511, indicating it pertains to medical and diagnostic laboratories. The solicitation was posted on July 23, 2026, with a mandatory response deadline of July 28, 2026, at 9:00 PM Eastern Time. The place of performance and exact office address are not specified, suggesting flexibility in where the testing may be performed, provided it meets required standards and timelines. The nature of the work reflects a critical diagnostic function supporting veteran healthcare, requiring precise and reliable laboratory capabilities for fungal pathogen identification.

250-NETWORK Contract Office 10 (36C250)

POSTED

DEADLINE

Clinical Laboratory Specimen Collection and ProcessingThe contract entails the collection, labeling, and initial processing of biological specimens from participants in a clinical trial conducted at military hospitals in Douala and Yaoundé, with rigorous adherence to cold-chain protocols to ensure sample integrity. All activities must comply with standardized timelines and environmental controls to maintain the validity of specimens throughout handling and transport, reflecting the high-stakes nature of clinical research in a deployed military healthcare setting. The work is a subcontract under the Department of Defense, specifically managed by the Navsup Flc Sigonella Naples Office, and is tied to the NAICS code for medical and diagnostic laboratories. The solicitation was posted on July 23, 2026, with a response deadline of August 7, 2026, at 8:00 a.m., allowing prospective vendors a focused window to submit proposals. Performance will occur exclusively at designated military medical facilities in Cameroon, requiring contractors to demonstrate local operational capacity, familiarity with military medical protocols, and experience in managing sensitive biological materials under strict regulatory and logistical constraints. There is no set-aside designation provided, and while the exact funding source or contract value is not indicated, the nature of the work implies a specialized, high-compliance environment demanding precision and reliability in all stages of specimen handling.

Navsup Flc Sigonella Naples Office

POSTED

DEADLINE

Q301--Intent to Sole Source - Diagnostics Fungal Testing Services Indianapolis, INThe Department of Veterans Affairs, through Network Contracting Office 10, has issued a Notice of Intent to Sole Source a Firm Fixed Price Indefinite Delivery Indefinite Quantity contract to MiraVista Diagnostics LLC for specialized fungal diagnostic testing services. This action is non-competitive and justified under FAR 6.302-1(b) and RFO 6.103-1(b), as market research has identified MiraVista Diagnostics LLC as the only responsible source capable of providing the required tests, including quantitative antigen and antibody testing by enzyme immunosorbent assay for Histoplasma, Blastomyces, Coccidioides, and Aspergillus; Beta-D Glucan testing via colorimetric assay; and multiple PCR assays for Pneumocystis, Histoplasma, Blastomyces, Coccidioides, and a Pulmonary Fungal Pathogen Panel. The contract falls under NAICS code 621511 for Medical Laboratories with a size standard of $41,500,000 and is classified under Product Service Code Q301 for Medical Reference Laboratory Testing. The procurement is structured under FAR Part 12 as a commercial item acquisition, and no formal proposals or cost submissions are requested; responses to this notice are purely informational and do not create any entitlement to payment or cost reimbursement. The contract will be performed on an as-needed basis with no fixed volume or schedule, and while the contracting office is located in Ann Arbor, Michigan, the statement of work references performance potentially linked to Indianapolis, Indiana. The sole source determination is based on the unique technical capabilities of MiraVista Diagnostics LLC under 41 USC 1901, and the Government retains full authority for inspection and acceptance of deliverables based on compliance with the specified test methodologies and regulatory standards. No specific payment office, invoice submission system, packaging requirements, or evaluation factors are detailed, as this is a pre-solicitation notice. All information received in response to this announcement will be used solely to assess whether competition is feasible, with the final decision on sole source award resting entirely with the Government. Responses must be submitted by July 28, 2026, to the designated point of contact, Kait Nachtrab, Contract Specialist at the VA Network Contracting Office.

250-NETWORK Contract Office 10 (36C250)

POSTED

DEADLINE

On Site Diagnostic Imaging – Ontario RegionThe Correctional Service of Canada requires on-site diagnostic ultrasound imaging services for offenders at designated institutions across the Ontario Region, excluding the National Capital Region, under a contract spanning from September 1, 2026, to August 30, 2030. The services must be delivered in accordance with professional medical standards and the mandated practices for ultrasound imaging in Ontario, ensuring compliance with all relevant laws, regulations, and the National Essential Health Care Framework. The Contractor, a registered business authorized to provide diagnostic medical sonography services in Ontario, must perform clinics according to a schedule approved by the Project Authority, handling a minimum of four cases per clinic and up to eight cases with mutual agreement, generating clear diagnostic reports within one week for routine referrals and within 24 hours for urgent cases. The estimated volume is approximately 225 cases annually, totaling 900 cases over the contract term, with additional services such as quality improvement meetings capped at a maximum of 12 hours over the four-year period. The contract is awarded on a lowest priced technically acceptable basis, with mandatory pass/fail criteria requiring bidders to be in good standing and authorized to practice in Ontario, and each proposed sonographer to have at least three years of diagnostic medical sonography experience within the past five years. Financial bids must strictly follow the prescribed format, and noncompliance results in immediate disqualification. All services are billed at firm unit or all-inclusive hourly rates, with payments made monthly via electronic means upon submission of detailed invoices that include case counts, hours, and tax information. The Contractor must adhere to stringent security protocols, including holding a valid Designated Organization Screening and ensuring all personnel accessing protected sites have reliable status clearance; electronic handling of protected information is prohibited, and personal devices cannot connect to government systems. Insurance coverage meeting Annex D requirements must be maintained and certified within ten days of award, while infection control must meet provincial sterilization standards, subject to biannual audits of autoclave records. Travel, relocation, and living expenses are included in the all-inclusive rates, and only Canadian suppliers are eligible under the Policy on Reciprocal Procurement, with no set-asides for Indigenous businesses. The contract is governed by Standard Acquisition Clauses and Conditions, with priority given to the Articles of Agreement, followed by supplemental conditions, general conditions, and annexes, and Canada retains audit rights to recover inaccurate payments. Bids must be submitted via email as three PDF sections—technical, financial, and certifications—within a 10 MB

Correctional Service of Canada

POSTED

DEADLINE